CANNA BIOMARKERS | ITZHAK KUREK, PHD
BLUNTZ
One of the stigmas holding back the acceptance of medical canna, especially within the medical community, is the lack of information in a format they are trained to receive, analyze and utilize it in. On this episode of Let’s Be Blunt, Montel talks with the CEO Cannaformatics, Dr Itzhak Kurek, about how they are working to change that paradigm. Dr Kurek has published 20 peer reviewed scientific papers and holds 13 granted US and international patents cited over 2,000 times. He received his Ph.D. in Plant Sciences from Tel Aviv University and completed his postdoctoral research at the University of California, Davis, and has conducted research at the Technical University of Munich, John Innes Center Norwich, C.N.R.S Bordeaux and the Lawrence Berkeley National Laboratories. Dr Kurek discusses how Cannaformatics is identifying canna biomarkers, and how that information will benefit patients and medical practicioners in the near future.
To see the whole interview go to https://youtu.be/9x_P0IEZFaU
-
1:48
keithmclaughlin
1 year agoCANNA BIOMARKERS | ITZHAK KUREK, PHD
7 -
1:15
keithmclaughlin
1 year agoINTEGRATIVE MEDICINE | DR MIKHAIL KOGAN
4 -
41:50
tErPwErKz710
10 months agoWHAT IS HHC? Hexahydrocannabinol...Late Night Dabs
509 -
1:28:19
Tuckergoodrich
3 months agoEp. 16: Understanding HNE, Biomarkers, and LPO—with Matt Quinn and Dr. Brian Kerley
41 -
23:30
The Talking Hedge
1 year agoWhat if Cannabis Regulation Wasn't a Factor
9 -
26:34
The Talking Hedge
1 year agoThe Science of Cannabis Testing
10 -
1:12:04
BaggyPants
3 months agoICYMI- Cannabis vs Cancer
221 -
2:25
TheDrillDown.com
3 years agoNEW GAI Report Exposes Corruption and Cronyism in the Cannabis Industry
1741 -
0:56
The Talking Hedge
6 months agoToo Many F*cking Cannabis SKUs
222 -
53:12
HEALTH EXPOSED By Health Revival Partners
3 months ago153. Cancer Biomarkers - Deep Dive
1541